Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Baxter renal replacement

This article was originally published in The Gray Sheet

Executive Summary

Promotion of 30-year Baxter veteran Carlos de Salto to division president marks most recent move to revitalize business, as former Renal President Al Heller resigns to become a life sciences advisor to One Equity Partners. In 2002, Baxter initiated divestiture of the majority of its renal dialysis services, in favor of strengthening peritoneal and home dialysis offerings (1"The Gray Sheet" Dec. 9, 2002, p. 19)...

You may also be interested in...

Baxter Renal Services Divestment May Strengthen Home Health Care Business

Baxter International aims to expand its peritoneal and hemodialysis product offerings, particularly in the home setting, following a planned divestiture of the majority of its renal dialysis services

US FDA Pharmaceutical Quality Office Lauds Continuous Manufacturing Approvals

The FDA’s OPQ touts approval of sixth and seventh continuously manufactured drugs and quicker delivery of inspection results in latest annual report.

Warning Letter Roundup & Recap – 19 February 2020

No device-related warning letters were released by the US FDA the week of 19 February.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts